341 related articles for article (PubMed ID: 24024702)
1. Alzheimer's disease: pathophysiology and applications of magnetic nanoparticles as MRI theranostic agents.
Amiri H; Saeidi K; Borhani P; Manafirad A; Ghavami M; Zerbi V
ACS Chem Neurosci; 2013 Nov; 4(11):1417-29. PubMed ID: 24024702
[TBL] [Abstract][Full Text] [Related]
2. Multifunctional Superparamagnetic Iron Oxide Nanoparticles Conjugated with Aβ Oligomer-Specific scFv Antibody and Class A Scavenger Receptor Activator Show Early Diagnostic Potentials for Alzheimer's Disease.
Liu XG; Zhang L; Lu S; Liu DQ; Zhang LX; Yu XL; Liu RT
Int J Nanomedicine; 2020; 15():4919-4932. PubMed ID: 32764925
[TBL] [Abstract][Full Text] [Related]
3. Nanotechnologies for Alzheimer's disease: diagnosis, therapy, and safety issues.
Brambilla D; Le Droumaguet B; Nicolas J; Hashemi SH; Wu LP; Moghimi SM; Couvreur P; Andrieux K
Nanomedicine; 2011 Oct; 7(5):521-40. PubMed ID: 21477665
[TBL] [Abstract][Full Text] [Related]
4. Influence of the physiochemical properties of superparamagnetic iron oxide nanoparticles on amyloid β protein fibrillation in solution.
Mahmoudi M; Quinlan-Pluck F; Monopoli MP; Sheibani S; Vali H; Dawson KA; Lynch I
ACS Chem Neurosci; 2013 Mar; 4(3):475-85. PubMed ID: 23509983
[TBL] [Abstract][Full Text] [Related]
5. Effect of PEGylated superparamagnetic iron oxide nanoparticles (SPIONs) under magnetic field on amyloid beta fibrillation process.
Mirsadeghi S; Shanehsazzadeh S; Atyabi F; Dinarvand R
Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():390-397. PubMed ID: 26652388
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in superparamagnetic iron oxide nanoparticles (SPIONs) for in vitro and in vivo cancer nanotheranostics.
Kandasamy G; Maity D
Int J Pharm; 2015 Dec; 496(2):191-218. PubMed ID: 26520409
[TBL] [Abstract][Full Text] [Related]
7. PEGylated superparamagnetic iron oxide nanoparticles (SPIONs) ameliorate learning and memory deficit in a rat model of Alzheimer's disease: Potential participation of STIMs.
Sanati M; Aminyavari S; Khodagholi F; Hajipour MJ; Sadeghi P; Noruzi M; Moshtagh A; Behmadi H; Sharifzadeh M
Neurotoxicology; 2021 Jul; 85():145-159. PubMed ID: 34058247
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of superparamagnetic iron oxide nanoparticles coated with a DDNP-carboxyl derivative for in vitro magnetic resonance imaging of Alzheimer's disease.
Zhou J; Fa H; Yin W; Zhang J; Hou C; Huo D; Zhang D; Zhang H
Mater Sci Eng C Mater Biol Appl; 2014 Apr; 37():348-55. PubMed ID: 24582259
[TBL] [Abstract][Full Text] [Related]
9. Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy.
Zhu L; Zhou Z; Mao H; Yang L
Nanomedicine (Lond); 2017 Jan; 12(1):73-87. PubMed ID: 27876448
[TBL] [Abstract][Full Text] [Related]
10. Preparation of Amyloid Immuno-Nanoparticles as Potential MRI Contrast Agents for Alzheimer's Disease Diagnosis.
Yin Z; Yul T; Xu Y
J Nanosci Nanotechnol; 2015 Sep; 15(9):6429-34. PubMed ID: 26716196
[TBL] [Abstract][Full Text] [Related]
11. Nanotheranostics: Congo Red/Rutin-MNPs with Enhanced Magnetic Resonance Imaging and H2O2-Responsive Therapy of Alzheimer's Disease in APPswe/PS1dE9 Transgenic Mice.
Hu B; Dai F; Fan Z; Ma G; Tang Q; Zhang X
Adv Mater; 2015 Oct; 27(37):5499-505. PubMed ID: 26270904
[TBL] [Abstract][Full Text] [Related]
12. Deciphering the Biochemical Pathway and Pharmacokinetic Study of Amyloid βeta-42 with Superparamagnetic Iron Oxide Nanoparticles (SPIONs) Using Systems Biology Approach.
Kaushik AC; Kumar A; Dwivedi VD; Bharadwaj S; Kumar S; Bharti K; Kumar P; Chaudhary RK; Mishra SK
Mol Neurobiol; 2018 Apr; 55(4):3224-3236. PubMed ID: 28478508
[TBL] [Abstract][Full Text] [Related]
13. Superparamagnetic iron oxide nanoparticles conjugated with Aβ oligomer-specific scFv antibody and class A scavenger receptor activator show therapeutic potentials for Alzheimer's Disease.
Liu XG; Zhang L; Lu S; Liu DQ; Huang YR; Zhu J; Zhou WW; Yu XL; Liu RT
J Nanobiotechnology; 2020 Nov; 18(1):160. PubMed ID: 33160377
[TBL] [Abstract][Full Text] [Related]
14. Amyloid β-targeted metal complexes for potential applications in Alzheimer's disease.
Liu H; Qu Y; Wang X
Future Med Chem; 2018 Mar; 10(6):679-701. PubMed ID: 29400551
[TBL] [Abstract][Full Text] [Related]
15. Gd-nanoparticles functionalization with specific peptides for ß-amyloid plaques targeting.
Plissonneau M; Pansieri J; Heinrich-Balard L; Morfin JF; Stransky-Heilkron N; Rivory P; Mowat P; Dumoulin M; Cohen R; Allémann É; Tόth É; Saraiva MJ; Louis C; Tillement O; Forge V; Lux F; Marquette C
J Nanobiotechnology; 2016 Jul; 14(1):60. PubMed ID: 27455834
[TBL] [Abstract][Full Text] [Related]
16. Curcumin-conjugated magnetic nanoparticles for detecting amyloid plaques in Alzheimer's disease mice using magnetic resonance imaging (MRI).
Cheng KK; Chan PS; Fan S; Kwan SM; Yeung KL; Wáng YX; Chow AH; Wu EX; Baum L
Biomaterials; 2015 Mar; 44():155-72. PubMed ID: 25617135
[TBL] [Abstract][Full Text] [Related]
17. Magnetic Nanoparticles: Current Trends and Future Aspects in Diagnostics and Nanomedicine.
Vallabani NVS; Singh S; Karakoti AS
Curr Drug Metab; 2019; 20(6):457-472. PubMed ID: 30465498
[TBL] [Abstract][Full Text] [Related]
18. Magnetic iron oxide nanoparticles as drug carriers: preparation, conjugation and delivery.
El-Boubbou K
Nanomedicine (Lond); 2018 Apr; 13(8):929-952. PubMed ID: 29546817
[TBL] [Abstract][Full Text] [Related]
19. Superparamagnetic nanoparticle-enhanced MRI of Alzheimer's disease plaques and activated microglia in 3X transgenic mouse brains: Contrast optimization.
Tafoya MA; Madi S; Sillerud LO
J Magn Reson Imaging; 2017 Aug; 46(2):574-588. PubMed ID: 27875002
[TBL] [Abstract][Full Text] [Related]
20. Amyloid Aβ
Tahirbegi IB; Pardo WA; Alvira M; Mir M; Samitier J
Nanotechnology; 2016 Nov; 27(46):465102. PubMed ID: 27734811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
